Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

nasdaq:abcl

POPULAR ARTICLES

AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635

AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635

AbCellera to Present at Upcoming Investor Conferences in May and June 2026

AbCellera to Present at Upcoming Investor Conferences in May and June 2026

AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

LATEST ARTICLES

AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026

AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026

AbCellera Reports Full Year 2025 Business Results

AbCellera Reports Full Year 2025 Business Results

AbCellera to Present at Upcoming Investor Conferences in March and April 2026

AbCellera to Present at Upcoming Investor Conferences in March and April 2026

AbCellera to Report Full Year 2025 Financial Results on February 24, 2026

AbCellera to Report Full Year 2025 Financial Results on February 24, 2026

AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause

AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause

AbCellera and Bruker Reach Global Settlement of Patent Litigation

AbCellera and Bruker Reach Global Settlement of Patent Litigation

AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

AbCellera Appoints Dr. Stephen Quake to its Board of Directors

AbCellera Appoints Dr. Stephen Quake to its Board of Directors

AbCellera Reports Q3 2025 Business Results

AbCellera Reports Q3 2025 Business Results

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Latest News

New Drill Program to Commence at Webbs

Extension to Rights Issue Closing Date

Standard Uranium Announces LIFE Offering

Skyharbour Closes $5.25 Million Private Placement of Flow-Through Shares

Goldgroup Files Updated Technical Report on San Francisco Gold Project

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Angkor Resources

Angkor Resources (ANK:CC)

ANK:CC

Morningstar

MORN

BriaCell Therapeutics

BriaCell Therapeutics (BCT:CC)

BCT:CC

EraNova Metals

EraNova Metals (NOVA:CC)

NOVA:CC

MetalSource Mining

MetalSource Mining (MSM:CC)

MSM:CC

LaFleur Minerals

LaFleur Minerals (LFLR:CC)

LFLR:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES